Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Nafamostat Mesilate”

21 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 21 results

Post-approval studies (Phase 4)Not Yet RecruitingNCT06078839
What this trial is testing

Nafamostat Mesilate in the Treatment of Severe Infection-associated Coagulopathy

Who this might be right for
SepsisSepsis-induced CoagulopathyNafamostat Mesilate
Xu Li 778
Not applicableUnknownNCT05382078
What this trial is testing

Nafamostat Mesilate for Anticoagulation During CRRT in Critically Ill Patients

Who this might be right for
Sepsis SyndromeMODSAKI+3 more
First Affiliated Hospital Xi'an Jiaotong University 188
Large-scale testing (Phase 3)Ended earlyNCT04390594
What this trial is testing

Efficacy and Safety Evaluation of Treatment Regimens in Adult COVID-19 Patients in Senegal

Who this might be right for
COVID-19
Institut Pasteur de Dakar 59
Not applicableNot Yet RecruitingNCT06994312
What this trial is testing

The Impact of Nafamostat Mesylate on the Prognosis of Patients With Sepsis-Induced Coagulopathy Undergoing Hemofiltration

Who this might be right for
Sepsis-induced Coagulopathy (SIC)
The First Hospital of Jilin University 282
Early research (Phase 1)Looking for participantsNCT06500793
What this trial is testing

Single Dose Study, Pharmacokinetics of Oxycodone and PF614 Co-Administered With Nafamostat (PF614-MPAR-102)

Who this might be right for
PharmacokineticsHealthy Volunteer
Ensysce Biosciences 54
Post-approval studies (Phase 4)Not Yet RecruitingNCT06375616
What this trial is testing

Comparison of Nafamostat and Unfractionated Heparin in RRT for Sepsis Associated AKI

Who this might be right for
Sepsis
Shen Lei 156
Large-scale testing (Phase 3)UnknownNCT04418128
What this trial is testing

Clinical Efficacy of Nafamostat Mesylate for COVID-19 Pneumonia

Who this might be right for
Corona Virus InfectionCOVID-19
Gyeongsang National University Hospital 84
Post-approval studies (Phase 4)Study completedNCT01761994
What this trial is testing

The Effect of Nafamostat Mesilate in Prolonging Filter Patency With Patients on Continuous Renal Replacement Therapy

Who this might be right for
Acute Kidney Injury
Yonsei University 66
Large-scale testing (Phase 3)UnknownNCT01486485
What this trial is testing

Nafamostat Efficacy and Safety in Critically Ill Patients(NICE)

Who this might be right for
Acute Kidney Injury
Seoul National University Hospital 160
Testing effectiveness (Phase 2)Looking for participantsNCT07469072
What this trial is testing

Comparison of Anticoagulant Effects of Different Doses of Nafamostat in Continuous Renal Replacement Therapy (CRRT) in the Intensive Care Unit (ICU)

Who this might be right for
Continuous Renal Replacement Therapy (CRRT)
Zhujiang Hospital 92
Early research (Phase 1)Study completedNCT04406415
What this trial is testing

Oral Nafamostat in Healthy Volunteers (NAF-101)

Who this might be right for
Pharmacokinetics
Ensysce Biosciences 17
Testing effectiveness (Phase 2)UnknownNCT05555641
What this trial is testing

Efficacy and Safety of Nafamostat Mesylate for VV-ECMO Anticoagulation

Who this might be right for
Critical IllnessAnticoagulation
Xiaobo Yang, MD 40
Not applicableLooking for participantsNCT06276010
What this trial is testing

Use of Nafamostat Mesilate for Anticoagulation in Patients With ECMO

Who this might be right for
Extracorporeal Membrane Oxygenation Complication
Xiaotong Hou 80
Post-approval studies (Phase 4)Study completedNCT01001403
What this trial is testing

Effect of Nafamostat on Postreperfusion Syndrome (PRS)

Who this might be right for
Liver TransplantationPostreperfusion Syndrome
Seoul National University Hospital 62
Not applicableLooking for participantsNCT06676085
What this trial is testing

A Novel Strategy of ECMO Management Using Nafamostat for Regional Combined With Low Intensity Systematic Anticoagulation

Who this might be right for
ECMO
Beijing Chao Yang Hospital 140
Large-scale testing (Phase 3)UnknownNCT04352400
What this trial is testing

Efficacy of Nafamostat in Covid-19 Patients (RACONA Study)

Who this might be right for
COVID19
University Hospital Padova 256
Post-approval studies (Phase 4)Not Yet RecruitingNCT07518303
What this trial is testing

Nafamostat Mesylate Versus Regional Citrate Anticoagulation for Continuous Renal Replacement Therapy in Sepsis-Associated Acute Kidney Injury

Who this might be right for
SepsisAcute Kidney InjuryContinuous Renal Replacement Therapy (CRRT)
Jianfeng Xie 1,162
Not applicableLooking for participantsNCT05874674
What this trial is testing

The Safety of Nafamostat Mesylate for Patients With High Risk Bleeding Undergoing Hemodialysis: A Pilot Study

Who this might be right for
Dialysis; ComplicationsBleeding
Wonju Severance Christian Hospital 100
Not applicableLooking for participantsNCT06150742
What this trial is testing

Nafamostat Efficacy in Phase 3 Registrational CRRT Study

Who this might be right for
Acute Kidney Injury
Talphera, Inc 70
Post-approval studies (Phase 4)Study completedNCT02478242
What this trial is testing

Trial to Assess the Efficacy and Safety of Nafamostat Mesilate During Continuous Renal Replacement Therapy

Who this might be right for
Acute Kidney Injury
Kyungpook National University Hospital 60
Next Page